Curative therapies for hepatocellular carcinoma: an update and perspectives

Rodolfo Sacco; Michela Antonucci; Giampaolo Bresci; Ambra Corti; Luca Giacomelli; Valeria Mismas; Maurizio Rainieri; Antonio Romano; Roberto Eggenhoffner; Emanuele Tumino; Giuseppe Cabibbo

doi:10.1586/14737140.2016.1123625

Curative therapies for hepatocellular carcinoma: an update and perspectives

Expert Rev Anticancer Ther. 2016;16(2):169-75. doi: 10.1586/14737140.2016.1123625. Epub 2015 Dec 14.

Affiliations

¹ a Department of Gastroenterology , Pisa University Hospital , Pisa , Italy.
² b Section of Radiology - Di.Bi.Me.F. , University of Palermo , Palermo , Italy.
³ c Free Researcher , Milan , Italy.
⁴ d Department of Surgical Sciences and Integrated Diagnostics, School of Medicine , Genova University , Genoa , Italy.
⁵ e Section of Gastroenterology - Di.Bi.M.I.S. , University of Palermo , Palermo , Italy.

PMID: 26588992
DOI: 10.1586/14737140.2016.1123625

Abstract

Curative treatments, including liver transplantation, surgical resection and percutaneous treatments, are the recommended therapies in BCLC-0 (Barcelona Clinic of Liver Cancer) or BCLC-A hepatocellular carcinoma (HCC). This review provides an overview of some issues of clinical importance concerning curative treatments in HCC.

Keywords: Ablative therapy; HCC; PEI; RFA; early stage; liver transplant; resection.

Publication types

Review

MeSH terms

Ablation Techniques / methods
Carcinoma, Hepatocellular / pathology
Carcinoma, Hepatocellular / surgery*
Hepatectomy / methods
Humans
Liver Neoplasms / pathology
Liver Neoplasms / surgery*
Liver Transplantation / methods*